Clinical study of CT-03
Latest Information Update: 14 Mar 2023
At a glance
- Drugs CT-03 (Primary)
- Indications Haematological malignancies; Solid tumours
- Focus Adverse reactions
Most Recent Events
- 14 Mar 2023 New trial record
- 07 Mar 2023 According to a Captor Therapeutics media release, the company expect to initiate this trial in 2024 and data is expected in 2025.